Clinical Trial

A Study to Evaluate Novel KarX and KarT Prototypes Versus the KarXT and KarX-EC Reference Following Single Doses, and to Explore the Effect of Food After Multiple Doses of Selected Prototypes in Healthy Adult Participants

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate novel KarX and KarT prototypes versus the KarXT and KarX-EC reference following single doses, and to explore the effect of food after multiple doses of selected prototypes in healthy adult participants.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-11; most recent amendment 2026-07-07.
Trial Details
NCT Number NCT07063342
Lead Sponsor Bristol-Myers Squibb
Conditions Healthy Volunteers
Enrollment 72 participants
Start Date 2025-06-27
Primary Completion 2027-03-29 (estimated)
Study Completion 2027-03-29 (estimated)
Updated on ClinicalTrials.gov 2026-07-09